scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M006613200 |
P698 | PubMed publication ID | 10969084 |
P2093 | author name string | Lee JM | |
Chan G | |||
White JR | |||
Foley JJ | |||
Sarau HM | |||
Schmidt DB | |||
Christmann LT | |||
Darcy MG | |||
Dhanak D | |||
Fornwald JA | |||
Jurewicz AJ | |||
Widdowson KL | |||
Imburgia CS | |||
Dede K | |||
P2860 | cites work | The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 | Q57019223 |
C-C Chemokine Receptor 3 Antagonism by the -Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap | Q57130759 | ||
Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist | Q59065030 | ||
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding | Q67485755 | ||
Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig | Q68281630 | ||
Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production | Q72376935 | ||
The inflammatory nature of allergic disease | Q78167508 | ||
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 | Q22010429 | ||
Identification of receptors for neuromedin U and its role in feeding | Q22254611 | ||
Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B | Q24312103 | ||
Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells | Q24312942 | ||
Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody | Q24561853 | ||
The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes | Q24653022 | ||
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes | Q24669740 | ||
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR | Q24675425 | ||
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils | Q24678192 | ||
Cloning, expression, and characterization of the human eosinophil eotaxin receptor | Q24678271 | ||
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation | Q24680123 | ||
Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3 | Q28278947 | ||
Cloning and functional expression of a human eosinophil CC chemokine receptor | Q28294129 | ||
A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor | Q28343083 | ||
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity | Q28343321 | ||
A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. | Q31395542 | ||
Pathogenesis of atopic dermatitis | Q33731176 | ||
Chemokines active on eosinophils: potential roles in allergic inflammation | Q36366779 | ||
Properties of the novel proinflammatory supergene "intercrine" cytokine family. | Q37357898 | ||
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines | Q37364354 | ||
Eotaxin: a VIC (very important chemokine) of allergic inflammation? | Q39759595 | ||
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors | Q40920168 | ||
Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor | Q41032296 | ||
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. | Q41071776 | ||
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. | Q41091668 | ||
Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. | Q41229926 | ||
Characterisation of the RANTES/MIP-1 alpha receptor (CC CKR-1) stably transfected in HEK 293 cells and the recombinant ligands. | Q41269142 | ||
Chemokines: what chemokine is that? | Q41510862 | ||
Chemokine receptors and T cell chemotaxis | Q42016350 | ||
The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness | Q42417164 | ||
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration | Q42543239 | ||
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. | Q42596329 | ||
Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia | Q42947733 | ||
Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle | Q43260751 | ||
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils | Q43750645 | ||
Effect of the dopamine beta-hydroxylase inhibitor, SK&F 102698, on blood pressure in the 1-kidney, 1-clip hypertensive dog. | Q50136474 | ||
P433 | issue | 47 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chemotaxis | Q658145 |
P304 | page(s) | 36626-36631 | |
P577 | publication date | 2000-11-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration | |
P478 | volume | 275 |
Q34994975 | Asthma: future directions |
Q35743287 | Biochemical assessment of intracellular signal transduction pathways in eosinophils: implications for pharmacotherapy |
Q44795042 | CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2. |
Q92146450 | CCR3 antagonist impairs estradiol-induced eosinophil migration to the uterus in ovariectomized mice |
Q35091280 | CCR3: a key to mast cell phenotypic and functional diversity? |
Q37481238 | Chemokine receptor antagonists: Part 1. |
Q37721300 | Chemokines and their receptors in the allergic airway inflammatory process. |
Q37442685 | Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: a review. |
Q40220734 | Chemokines induce axon outgrowth downstream of Hepatocyte Growth Factor and TCF/β-catenin signaling |
Q35561670 | Cytokine-directed therapies for the treatment of chronic airway diseases |
Q30671170 | Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. |
Q43621563 | Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2. |
Q37039453 | Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites |
Q79949175 | Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects |
Q41875485 | Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis. |
Q28362893 | Eotaxin and the attraction of eosinophils to the asthmatic lung |
Q30779108 | Functional inhibition of CCR3-dependent responses by peptides derived from phage libraries |
Q35065927 | G protein-coupled receptors--recent advances |
Q53653346 | Identification and characterization of novel antagonists of the CCR3 receptor. |
Q40687718 | Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding |
Q57462537 | Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants |
Q44636885 | Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor |
Q34743328 | New therapeutics that modulate chemokine networks |
Q37415334 | Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. |
Q57181974 | Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness |
Q42024121 | PI3K, ERK, p38 MAPK and integrins regulate CCR3-mediated secretion of mouse and human eosinophil-associated RNases |
Q27003331 | Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field |
Q36201583 | Pharmacological management of nasal polyposis |
Q38196934 | Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4. |
Q44031732 | Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists |
Q53328522 | Role of chemokine (C-C motif) ligand 24 in spatial arrangement of the inner cell mass of the bovine embryo. |
Q34734980 | Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation |
Q47271733 | Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists. |
Q36165903 | Selective suppression of leukocyte recruitment in allergic inflammation |
Q37670242 | Targeting CCL11 in the treatment of ovarian cancer |
Q54109145 | The Orphan G Protein-coupled Receptor 75 Signaling is Activated by the Chemokine CCL5. |
Q37738100 | The role of local steroid injection for nasal polyposis |
Search more.